Company profile
Adelle Diagnostics company profile
Adelle Diagnostics develops AI-based platforms for biomarker identification and blood-based diagnostic tests targeting neurodegenerative diseases, including normal pressure hydrocephalus. The company uses molecular technologies combined with data analysis to support accurate diagnosis and predict treatment outcomes, such as shunt surgery benefits. It integrates multi-omics data and machine learning to assist in personalized medical decision-making.
Business identity
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00001-00010 employees
- Founded
- 2021-02-01
Headquarters
- Headquarters
- Cairnbrook, Pennsylvania, United States
- Postal code
- 02906
- Country code
- US
- Continent
- North America